atbtherapeutics

📍 Aye, Belgium👥 19 employees💰 Last funded 2024
Biotechnology Research
LinkedIn
atbtherapeutics is a pioneering biopharmaceutical company building a new line of attack against cancer. atbtherapeutics has developed the atbody; a game-changer biologic format designed to broaden the therapeutic window of antibody-based therapies. Only our proprietary and versatile plant-based atbiofarm technology enables single-step manufacturing of our novel class of therapeutic atbodies. The resulting therapeutics offer a novel mechanism of action, avoiding major cancer cell resistance, and provide a promising, life-changing therapy for hard-to-treat and refractory cancer.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Netherlands
1
Germany
1
Frequently asked questions
Who invested in atbtherapeutics?
atbtherapeutics has 2 investors on record on gritt.io.
When did atbtherapeutics last raise funding?
The most recent investment in atbtherapeutics recorded on gritt.io was in 2024.
What industry is atbtherapeutics in?
atbtherapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is atbtherapeutics based?
atbtherapeutics is headquartered in Aye, Belgium.